C12Y 114/13013
Calcidiol 1-monooxygenase , i.e. 25-hydroxyvitamin d-1-alpha-hydroxylase
Official title: Calcidiol 1-monooxygenase (1.14.13.13), i.e. 25-hydroxyvitamin D-1-alpha-hydroxylase
C12Y114/13013 (Calcidiol 1-monooxygenase , i.e. 25-hydroxyvitamin d-1-alpha-hydroxylase) appears on 6 US grants and 10 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 10
- Assignees
- 8
- Inventors
- 23
- Latest grant
- 15 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 3 | 3 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- Method for utilizing engineered dendritic cells to induce gut-homing regulatory T cells and treat gut inflammation15 Apr 2025US 12,275,961 B2Loma Linda University
- Method for utilizing engineered dendritic cells to induce gut-homing regulatory T cells and treat gut inflammation3 Mar 2020US 10,577,669 B2Loma Linda University
- Expression vector for pseudonocardia autotrophica14 Apr 2015US 9,006,412 B2Microbiopharm Japan Co., Ltd.
- Agents and method for treating inflammation-related conditions and diseases13 May 2014US 8,722,399 B1Loma Linda University
- Agents and method for treating inflammation-related conditions and diseases11 Mar 2014US 8,669,104 B1Loma Linda University
- Modified uricase and uses thereof4 Jan 2024US 2024/0002814 A1Protalix Ltd.
- Engineered hematopoietic stem cells for the treatment of acute myeloid leukemia19 Aug 2021US 2021/0252072 A1Faculty Physicians and Surgeons of Loma Linda University School of Medicine
- Method for utilizing engineered dendritic cells to induce gut-homing regulatory t cells and treat gut inflammation14 May 2020US 2020/0149121 A1Loma Linda University
- A method for utilizing engineered dendritic cells to induce gut-homing regulatory t cells and treat gut inflammation1 Feb 2018US 2018/0030553 A1Loma Linda University
- Agents and method for treating inflammation-related conditions and diseases7 Aug 2014US 2014/0220677 A1Loma Linda University
Most cited
By later US patents
- Agents and method for treating inflammation-related conditions and diseases2US 8,647,616 B2Loma Linda University · 2014
- Agents and method for treating inflammation-related conditions and diseases2US 8,669,104 B1Loma Linda University · 2014
- Agents and method for treating inflammation-related conditions and diseases2US 8,722,399 B1Loma Linda University · 2014